BB1 logo

BlinkLab Stock Price

Symbol: ASX:BB1Market Cap: AU$55.7mCategory: Healthcare

BB1 Share Price Performance

BB1 Community Fair Values

    Recent BB1 News & Updates

    No updates

    BlinkLab Limited Key Details

    AU$194.9k

    Revenue

    AU$729.9k

    Cost of Revenue

    -AU$535.0k

    Gross Profit

    AU$3.3m

    Other Expenses

    -AU$3.8m

    Earnings

    Last Reported Earnings
    Dec 31, 2024
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -0.031
    Gross Margin
    -274.54%
    Net Profit Margin
    -1,972.85%
    Debt/Equity Ratio
    0%

    BlinkLab Limited Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About BB1

    Founded
    2021
    Employees
    n/a
    CEO
    Hendrikus Boele
    WebsiteView website
    www.blinklab.org

    BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing. The company’s smartphone-based application serves as a device for conducting neurobehavioral evaluations. Its application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia. The company was incorporated in 2021 and is based in Sydney, Australia.

    Australian Market Performance

    • 7 Days: 0.2%
    • 3 Months: 7.6%
    • 1 Year: 8.9%
    • Year to Date: 5.7%
    The market has been flat over the last week. As for the longer term, the market has risen 8.9% in the past 12 months. Looking forward, earnings are forecast to grow by 11% annually. Market details ›
    Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
    Continue reading